These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3500161)

  • 1. beta-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance.
    Livermore DM; Chau PY; Wong AI; Leung YK
    J Antimicrob Chemother; 1987 Sep; 20(3):313-21. PubMed ID: 3500161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of cephalosporinase from Proteus morganii.
    Toda M; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1981 Nov; 34(11):1469-75. PubMed ID: 6976340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible beta-lactamases in clinical isolates of non-aeruginosa Pseudomonas.
    Ravaoarinoro M; Toma E; Fallara A
    APMIS; 1992 Jun; 100(6):523-30. PubMed ID: 1610551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Properties of a cephalosporinase produced by Proteus penneri inhibited by clavulanic acid].
    Miro E; Barthelemy M; Peduzzi J; Reynaud A; Morand A; Prats G; Labia R
    Pathol Biol (Paris); 1994 May; 42(5):487-90. PubMed ID: 7824319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme.
    Rasmussen BA; Keeney D; Yang Y; Bush K
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2078-85. PubMed ID: 7811022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of a cephalosporinase susceptible to clavulanic acid in a clinical strain of Serratia fonticola].
    Farzaneh S; Péduzzi J; Demachy MC; Barthélémy M; Labia R
    Pathol Biol (Paris); 1995 Apr; 43(4):315-9. PubMed ID: 7567122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
    Neu HC
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):313-6. PubMed ID: 6321094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and properties of a new beta-lactamase from Pseudomonas cepacia.
    Hirai K; Iyobe S; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Mar; 17(3):355-8. PubMed ID: 6968539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli.
    Takahashi I; Sawai T; Ando T; Yamagishi S
    J Antibiot (Tokyo); 1980 Sep; 33(9):1037-42. PubMed ID: 7002896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
    Sawai T; Tsukamoto K
    J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE; Hart CA; McLennan AG; Aspinall S
    J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri.
    Matsuura M; Nakazawa H; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Nov; 18(5):687-90. PubMed ID: 6969578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cephalosporinases from Bacteroides fragilis, Bacteroides thetaiotaomicron and Bacteroides vulgatus.
    Sato K; Matsuura Y; Miyata K; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1983 Jan; 36(1):76-85. PubMed ID: 6332105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
    Kazmierczak A; Cordin X; Duez JM; Siebor E; Pechinot A; Sirot J
    J Int Med Res; 1990; 18 Suppl 4():67D-77D. PubMed ID: 2282971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five novel plasmid-determined beta-lactamases.
    Medeiros AA; Cohenford M; Jacoby GA
    Antimicrob Agents Chemother; 1985 May; 27(5):715-9. PubMed ID: 3925874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of a beta-lactamase from Proteus penneri.
    Grace ME; Gregory FJ; Hung PP; Fu KP
    J Antibiot (Tokyo); 1986 Jul; 39(7):938-42. PubMed ID: 3489701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
    Eley A; Greenwood D
    J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.
    Hiraoka M; Inoue M; Mitsuhashi S
    Rev Infect Dis; 1988; 10(4):746-51. PubMed ID: 3055173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple antibiotic resistance (MAR) index and its reversion in Pseudomonas aeruginosa.
    Paul S; Bezbaruah RL; Roy MK; Ghosh AC
    Lett Appl Microbiol; 1997 Mar; 24(3):169-71. PubMed ID: 9080693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.